Literature DB >> 35858355

Allosteric role of a structural NADP+ molecule in glucose-6-phosphate dehydrogenase activity.

Xuepeng Wei1,2, Kathryn Kixmoeller3, Elana Baltrusaitis3, Xiaolu Yang4, Ronen Marmorstein1,2,3.   

Abstract

Human glucose-6-phosphate dehydrogenase (G6PD) is the main cellular source of NADPH, and thus plays a key role in maintaining reduced glutathione to protect cells from oxidative stress disorders such as hemolytic anemia. G6PD is a multimeric enzyme that uses the cofactors β-D-glucose 6-phosphate (G6P) and "catalytic" NADP+ (NADP+c), as well as a "structural" NADP+ (NADP+s) located ∼25 Å from the active site, to generate NADPH. While X-ray crystallographic and biochemical studies have revealed a role for NADP+s in maintaining the catalytic activity by stabilizing the multimeric G6PD conformation, other potential roles for NADP+s have not been evaluated. Here, we determined the high resolution cryo-electron microscopy structures of human wild-type G6PD in the absence of bound ligands and a catalytic G6PD-D200N mutant bound to NADP+c and NADP+s in the absence or presence of G6P. A comparison of these structures, together with previously reported structures, reveals that the unliganded human G6PD forms a mixture of dimers and tetramers with similar overall folds, and binding of NADP+s induces a structural ordering of a C-terminal extension region and allosterically regulates G6P binding and catalysis. These studies have implications for understanding G6PD deficiencies and for therapy of G6PD-mediated disorders.

Entities:  

Keywords:  G6PD; NADPH; allostery; cryo-EM

Mesh:

Substances:

Year:  2022        PMID: 35858355      PMCID: PMC9303983          DOI: 10.1073/pnas.2119695119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  25 in total

1.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

2.  Human glucose-6-phosphate dehydrogenase: the crystal structure reveals a structural NADP(+) molecule and provides insights into enzyme deficiency.

Authors:  S W Au; S Gover; V M Lam; M J Adams
Journal:  Structure       Date:  2000-03-15       Impact factor: 5.006

Review 3.  Glucose-6-phosphate dehydrogenase, NADPH, and cell survival.

Authors:  Robert C Stanton
Journal:  IUBMB Life       Date:  2012-03-20       Impact factor: 3.885

4.  Distinctive patterns of NADP binding to dimeric and tetrameric glucose 6-phosphate dehydrogenase from human red cells.

Authors:  A Bonsignore; I Lorenzoni; R Cancedda; A De Flora
Journal:  Biochem Biophys Res Commun       Date:  1970-04-08       Impact factor: 3.575

5.  Metabolism of human erythrocyte glucose-6-phosphate dehydrogenase. VI. Interconversion of multiple molecular forms.

Authors:  A Bonsignore; R Cancedda; A Nicolini; G Damiani; A De Flora
Journal:  Arch Biochem Biophys       Date:  1971-12       Impact factor: 4.013

6.  Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the "old" and update of the new mutations.

Authors:  Angelo Minucci; Kamran Moradkhani; Ming Jing Hwang; Cecilia Zuppi; Bruno Giardina; Ettore Capoluongo
Journal:  Blood Cells Mol Dis       Date:  2012-01-30       Impact factor: 3.039

7.  Structural studies of glucose-6-phosphate and NADP+ binding to human glucose-6-phosphate dehydrogenase.

Authors:  Masayo Kotaka; Sheila Gover; Lucy Vandeputte-Rutten; Shannon W N Au; Veronica M S Lam; Margaret J Adams
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-04-20

Review 8.  The pentose phosphate pathway and cancer.

Authors:  Krushna C Patra; Nissim Hay
Journal:  Trends Biochem Sci       Date:  2014-07-15       Impact factor: 13.807

9.  What is the role of the second "structural" NADP+-binding site in human glucose 6-phosphate dehydrogenase?

Authors:  Xiao-Tao Wang; Ting Fai Chan; Veronica M S Lam; Paul C Engel
Journal:  Protein Sci       Date:  2008-05-20       Impact factor: 6.725

Review 10.  Current investigations on clinical pharmacology and therapeutics of Glucose-6-phosphate dehydrogenase deficiency.

Authors:  Kaitlyn Ryan; Babu L Tekwani
Journal:  Pharmacol Ther       Date:  2020-12-14       Impact factor: 13.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.